Washington, DC, United States of America

William P Wiesmann

This inventor holds 39 USPTO granted patents and 23 published patent applications, plus 11 CIPO patents and 11 EPO patents, primarily in Chitosan Derivatives. Top assignees: Synedgen, Inc., Bioasyst, L.l.c., Sekos, Inc.. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William P Wiesmann. Retrieved from https://idiyas.com/inventor/william-p-wiesmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 

% Patents Active = 69.2

 

 

Average Co-Inventor Count = 2.7

ph-index = 15

Forward Citations = 2,292(Granted Patents)


Location History:

  • Bethesda, MD (US) (1995 - 2005)
  • Washington, DC (US) (2003 - 2022)
  • Chevy Chase, MD (US) (2020 - 2024)

Company Filing History:


Years Active: 1995-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chitosan Derivatives
Wound Healing
Microbial Control
Vascular Disorders
Oral Formulations
Trauma Treatment
Biofilm Disruption
Physiologic Monitoring
Emergency Life Support
Self-Contained Ventilator
Surgical Systems
Bleeding Control
39 patents (USPTO):Explore Patents

Title: **William P. Wiesmann: Innovator in Biomedical Treatments**

Introduction

William P. Wiesmann, based in Washington, DC, is a prominent inventor with a remarkable portfolio of 35 patents. His contributions to the biomedical field focus primarily on innovative methods to treat and prevent conditions resulting from exposure to radiation, trauma, or shock. Wiesmann's groundbreaking work not only aims to enhance patient outcomes but also addresses critical health challenges.

Latest Patents

Wiesmann's latest patents include significant advancements in therapeutic methods. One of his notable inventions discusses methods for the treatment or prevention of damage resulting from radiation exposure, trauma, or shock. This patent outlines a process for identifying subjects at risk and administering a compound that effectively reduces the severity of sepsis, thereby improving survival rates.

Another of his recent patents encompasses compositions and methods for treating diseases affecting the pulmonary system, such as cystic fibrosis. This invention details a treatment approach involving water-soluble polyglucosamine and derivatized polyglucosamine to manage respiratory or digestive disorders.

Career Highlights

Wiesmann has accumulated extensive experience in research and development, significantly influencing the biomedical industry. His tenure at Synedgen, Inc. stands out as a pivotal point in his career, allowing him to translate his innovative ideas into practical solutions that benefit patients and healthcare professionals alike.

Collaborations

Throughout his career, Wiesmann has collaborated with brilliant minds in the field, including colleagues Shenda M. Baker and Stacy M. Townsend. These partnerships have fostered an environment of creativity and innovation, enabling the development of effective treatment methods that align with current scientific needs.

Conclusion

William P. Wiesmann's dedication to innovation and his significant contributions to patenting new methods of treatment exemplify his role as a leader in biomedical research. His work not only enriches the scientific community but also holds promise for improving the quality of life for patients facing serious health challenges. The impact of his inventions may continue to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…